Molecular QC for Rifampicin-Resistant Mycobacterium Tuberculosis
Positive and negative controls are designed to help laboratories deliver reliable MTB-RIF testing results.
Read MorePosted by Steve Halasey | Nov 12, 2019 | Controls, Quality Systems, Respiratory Disease, Tuberculosis |
Positive and negative controls are designed to help laboratories deliver reliable MTB-RIF testing results.
Read MorePosted by Steve Halasey | Nov 12, 2019 | Molecular Diagnostics |
The new molecular diagnostic enables the direct detection of varicella-zoster virus DNA from both cutaneous and mucocutaneous swab specimens.
Read MorePosted by Steve Halasey | Nov 12, 2019 | Standards |
The tests provide reliable, standardized results to help clinicians manage the risk of infection and improve treatment of severely immunocompromised transplant patients.
Read MorePosted by Steve Halasey | Oct 21, 2019 | Anatomic Pathology |
Strategic partnership aims to improve patient outcomes and lower the cost of US healthcare by eliminating waste in laboratory testing.
Read MorePosted by Steve Halasey | Oct 15, 2019 | Cameras, Containers, Microscopy |
Artificial intelligence promises to deliver both better business and clinical outcomes
Read More